Rafferty Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,212	Closed	-$604K	–	1148
2024 Q2	$604K	Buy	2,212 +56	+3%	+$16.3K	﹤0.01%	911
2024 Q1	$746K	Buy	2,156 +29	+1%	+$9.54K	﹤0.01%	880
2023 Q4	$687K	Sell	2,127 -52	-2%	-$16.3K	﹤0.01%	896
2023 Q3	$781K	Buy	2,179 +91	+4%	+$35.1K	﹤0.01%	852
2023 Q2	$792K	Buy	2,088 +165	+9%	+$67.1K	﹤0.01%	872
2023 Q1	$921K	Buy	1,923 +79	+4%	+$37K	0.01%	817
2022 Q4	$775K	Buy	1,844 +701	+61%	+$283K	0.01%	812
2022 Q3	$477K	Buy	1,143 +618	+118%	+$308K	0.01%	865
2022 Q2	$260K	Sell	525 -136	-21%	-$70.8K	﹤0.01%	965
2022 Q1	$372K	Sell	661 -65	-9%	-$39.2K	﹤0.01%	1072
2021 Q4	$549K	Buy	726 +41	+6%	+$30.7K	﹤0.01%	1044
2021 Q3	$511K	Buy	685 +239	+54%	+$179K	﹤0.01%	1036
2021 Q2	$287K	Buy	446 +22	+5%	+$13.4K	﹤0.01%	1183
2021 Q1	$242K	Buy	424 +51	+14%	+$30.2K	﹤0.01%	1120
2020 Q4	$217K	Sell	373 -1,329	-78%	-$757K	﹤0.01%	967
2020 Q3	$877K	Buy	1,702 +1,220	+253%	+$618K	0.01%	593
2020 Q2	$218K	Buy	+482	New	+$213K	﹤0.01%	908
2017 Q3	–	Sell	-3,618	Closed	-$819K	–	595
2017 Q2	$819K	Buy	+3,618	New	+$788K	0.02%	398